<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM"><PMID Version="1">35062742</PMID><DateRevised><Year>2023</Year><Month>11</Month><Day>05</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Print">2076-393X</ISSN><JournalIssue CitedMedium="Print"><Volume>10</Volume><Issue>1</Issue><PubDate><Year>2022</Year><Month>Jan</Month><Day>06</Day></PubDate></JournalIssue><Title>Vaccines</Title><ISOAbbreviation>Vaccines (Basel)</ISOAbbreviation></Journal><ArticleTitle>The Burden of COVID-19 in Children and Its Prevention by Vaccination: A Joint Statement of the Israeli Pediatric Association and the Israeli Society for Pediatric Infectious Diseases.</ArticleTitle><ELocationID EIdType="pii" ValidYN="Y">81</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.3390/vaccines10010081</ELocationID><Abstract><AbstractText>As of October 2021, SARS-CoV-2 infections were reported among 512,613 children and adolescents in Israel (~33% of all COVID-19 cases). The 5-11-year age group accounted for about 43% (223,850) of affected children and adolescents. In light of the availability of the Pfizer-BioNTech BNT162b2 vaccine against COVID-19 for children aged 5-11 years, we aimed to write a position paper for pediatricians, policymakers and families regarding the clinical aspects of COVID-19 and the vaccination of children against COVID-19. The first objective of this review was to describe the diverse facets of the burden of COVID-19 in children, including the direct effects of hospitalization during the acute phase of the disease, multisystem inflammatory syndrome in children, long COVID and the indirect effects of social isolation and interruption in education. In addition, we aimed to provide an update regarding the efficacy and safety of childhood mRNA COVID-19 vaccination and to instill confidence in pediatricians regarding the benefits of vaccinating children against COVID-19. We reviewed up-to-date Israeli and international epidemiological data and literature regarding COVID-19 morbidity and its sequelae in children, vaccine efficacy in reducing COVID-19-related morbidity and SARS-CoV-2 transmission and vaccine safety data. We conducted a risk-benefit analysis regarding the vaccination of children and adolescents. We concluded that vaccines are safe and effective and are recommended for all children aged 5 to 11 years to protect them from COVID-19 and its complications and to reduce community transmissions. Based on these data, after weighing the benefits of vaccination versus the harm, the Israeli Ministry of Health decided to recommend vaccination for children aged 5-11 years.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Stein</LastName><ForeName>Michal</ForeName><Initials>M</Initials><Identifier Source="ORCID">0000-0002-0765-7326</Identifier><AffiliationInfo><Affiliation>Infectious Diseases and Infection Control Unit, Hillel Yaffe Medical Center, Hadera 3810101, Israel.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Rappaport Faculty of Medicine, Technion-Israel Institute of Technology, Haifa 3109601, Israel.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ashkenazi-Hoffnung</LastName><ForeName>Liat</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Department of Day Care Hospitalization, Schneider Children's Medical Center, Petah Tikva 4920235, Israel.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv-Yafo 6997801, Israel.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Greenberg</LastName><ForeName>David</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>The Pediatric Infectious Disease Unit, Soroka Medical Center, Be'er Sheva 8458900, Israel.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>The Faculty of Health Sciences, Joyce &amp; Irving Goldman Medical School at Ben Gurion University of the Negev, Be'er Sheva 8410501, Israel.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Dalal</LastName><ForeName>Ilan</ForeName><Initials>I</Initials><Identifier Source="ORCID">0000-0003-0802-9740</Identifier><AffiliationInfo><Affiliation>Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv-Yafo 6997801, Israel.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Pediatric Department, E. Wolfson Medical Center, Holon 5822012, Israel.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Livni</LastName><ForeName>Gilat</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv-Yafo 6997801, Israel.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Pediatrics A, Schneider Children's Medical Center, Petah Tikva 4920245, Israel.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Chapnick</LastName><ForeName>Gil</ForeName><Initials>G</Initials><Identifier Source="ORCID">0000-0002-5601-4300</Identifier><AffiliationInfo><Affiliation>Maccabi Healthcare Services, Tel Aviv-Yafo 6812509, Israel.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Stein-Zamir</LastName><ForeName>Chen</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Jerusalem District Health Office, Jerusalem 9137001, Israel.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Braun School of Public Health and Community Medicine, Faculty of Medicine, Hebrew University of Jerusalem, Jerusalem 9112102, Israel.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ashkenazi</LastName><ForeName>Shai</ForeName><Initials>S</Initials><Identifier Source="ORCID">0000-0001-7244-0679</Identifier><AffiliationInfo><Affiliation>Schneider Children's Medical Center, Petah Tikva 4920235, Israel.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Adelson School of Medicine, Ariel University, Ari'el 4070000, Israel.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hecht-Sagie</LastName><ForeName>Lior</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Maccabi Healthcare Services, Tel Aviv-Yafo 6812509, Israel.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Grossman</LastName><ForeName>Zachi</ForeName><Initials>Z</Initials><AffiliationInfo><Affiliation>Maccabi Healthcare Services, Tel Aviv-Yafo 6812509, Israel.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Adelson School of Medicine, Ariel University, Ari'el 4070000, Israel.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2022</Year><Month>01</Month><Day>06</Day></ArticleDate></Article><MedlineJournalInfo><Country>Switzerland</Country><MedlineTA>Vaccines (Basel)</MedlineTA><NlmUniqueID>101629355</NlmUniqueID><ISSNLinking>2076-393X</ISSNLinking></MedlineJournalInfo><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">COVID-19</Keyword><Keyword MajorTopicYN="N">adolescents</Keyword><Keyword MajorTopicYN="N">children</Keyword><Keyword MajorTopicYN="N">efficacy</Keyword><Keyword MajorTopicYN="N">risk-benefit</Keyword><Keyword MajorTopicYN="N">safety</Keyword><Keyword MajorTopicYN="N">transmission</Keyword><Keyword MajorTopicYN="N">vaccine</Keyword></KeywordList><CoiStatement>The authors declare no conflict of interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2021</Year><Month>11</Month><Day>30</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2021</Year><Month>12</Month><Day>23</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2021</Year><Month>12</Month><Day>29</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2022</Year><Month>1</Month><Day>22</Day><Hour>1</Hour><Minute>3</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2022</Year><Month>1</Month><Day>23</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2022</Year><Month>1</Month><Day>23</Day><Hour>6</Hour><Minute>1</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2022</Year><Month>1</Month><Day>6</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">35062742</ArticleId><ArticleId IdType="pmc">PMC8781684</ArticleId><ArticleId IdType="doi">10.3390/vaccines10010081</ArticleId><ArticleId IdType="pii">vaccines10010081</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Israeli Ministry of Health Corona Dashboard.  [(accessed on 29 March 2021)]; Available online:  https://datadashboard.health.gov.il/COVID-19/</Citation></Reference><Reference><Citation>Campbell F., Archer B., Laurenson-Schafer H., Jinnai Y., Konings F., Batra N., Pavlin B., Vandemaele K., Van Kerkhove M.D., Jombart T., et al. Increased transmissibility and global spread of SARS-CoV-2 variants of concern as at June 2021. Euro Surveill. 2021;26:2100509. doi: 10.2807/1560-7917.ES.2021.26.24.2100509.</Citation><ArticleIdList><ArticleId IdType="doi">10.2807/1560-7917.ES.2021.26.24.2100509</ArticleId><ArticleId IdType="pmc">PMC8212592</ArticleId><ArticleId IdType="pubmed">34142653</ArticleId></ArticleIdList></Reference><Reference><Citation>Public Health Services The COVID-19 Vaccine in the 5&#x2013;11 Age Group.  [(accessed on 29 November 2021)]; Available online:  https://www.gov.il/BlobFolder/news/03112021-04/he/NEWS_Corona_public-health-services-5-11-vaccine.pdf.</Citation></Reference><Reference><Citation>Home&#x2014;COVID 19 Scenario Model Hub.  [(accessed on 24 June 2021)].  Available online:  https://covid19scenariomodelinghub.org/viz.html.</Citation></Reference><Reference><Citation>Liguoro I., Pilotto C., Bonanni M., Ferrari M.E., Pusiol A., Nocerino A., Vidal E., Cogo P. SARS-COV-2 infection in children and newborns: A systematic review. Eur. J. Pediatr. 2020;179:1029&#x2013;1046. doi: 10.1007/s00431-020-03684-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00431-020-03684-7</ArticleId><ArticleId IdType="pmc">PMC7234446</ArticleId><ArticleId IdType="pubmed">32424745</ArticleId></ArticleIdList></Reference><Reference><Citation>Ben-Shimol S., Livni G., Megged O., Greenberg D., Danino D., Youngster I., Shachor-Meyouhas Y., Dabaja-Younis H., Scheuerman O., Mor M., et al. COVID-19 in a Subset of Hospitalized Children in Israel. J. Pediatr. Infect. Dis. Soc. 2021;10:757&#x2013;765. doi: 10.1093/jpids/piab035.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/jpids/piab035</ArticleId><ArticleId IdType="pmc">PMC8344587</ArticleId><ArticleId IdType="pubmed">34129032</ArticleId></ArticleIdList></Reference><Reference><Citation>Havers F.P., Whitaker M., Self J.L., Chai S.J., Kirley P.D., Alden N.B., Kawasaki B., Meek J., Yousey-Hindes K., Anderson E.J., et al. Hospitalization of Adolescents Aged 12-17 Years with Laboratory-Confirmed COVID-19&#x2014;COVID-NET, 14 States, March 1, 2020&#x2013;April 24, 2021. MMWR Morb. Mortal. Wkly. Rep. 2021;70:851&#x2013;857. doi: 10.15585/mmwr.mm7023e1.</Citation><ArticleIdList><ArticleId IdType="doi">10.15585/mmwr.mm7023e1</ArticleId><ArticleId IdType="pmc">PMC8191866</ArticleId><ArticleId IdType="pubmed">34111061</ArticleId></ArticleIdList></Reference><Reference><Citation>Daniels C.J., Rajpal S., Greenshields J.T., Rosenthal G.L., Chung E.H., Terrin M., Jeudy J., Mattson S.E., Law I.H., Borchers J., et al. Prevalence of Clinical and Subclinical Myocarditis in Competitive Athletes With Recent SARS-CoV-2 Infection: Results From the Big Ten COVID-19 Cardiac Registry. JAMA Cardiol. 2021;6:1078&#x2013;1087. doi: 10.1001/jamacardio.2021.2065.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamacardio.2021.2065</ArticleId><ArticleId IdType="pmc">PMC8160916</ArticleId><ArticleId IdType="pubmed">34042947</ArticleId></ArticleIdList></Reference><Reference><Citation>Oliver S. EtR Framework: Pfizer-BioNTech COVID-19 vaccine in children aged 5&#x2013;11 years 2021; Proceedings of the CDC ACIP Meeting; Atlanta, GA, USA. 2 November 2021.</Citation></Reference><Reference><Citation>Feldstein L.R., Tenforde M.W., Friedman K.G., Newhams M., Rose E.B., Dapul H., Soma V.L., Maddux A.B., Mourani P.M., Bowens C., et al. Characteristics and Outcomes of US Children and Adolescents with Multisystem Inflammatory Syndrome in Children (MIS-C) Compared With Severe Acute COVID-19. JAMA. 2021;325:1074&#x2013;1087. doi: 10.1001/jama.2021.2091.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.2021.2091</ArticleId><ArticleId IdType="pmc">PMC7905703</ArticleId><ArticleId IdType="pubmed">33625505</ArticleId></ArticleIdList></Reference><Reference><Citation>Ramadan M.S., Bertolino L., Zampino R., Durante-Mangoni E. Monaldi Hospital Cardiovascular Infection Study Group Cardiac sequelae after coronavirus disease 2019 recovery: A systematic review. Clin. Microbiol. Infect. 2021;27:1250&#x2013;1261. doi: 10.1016/j.cmi.2021.06.015.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cmi.2021.06.015</ArticleId><ArticleId IdType="pmc">PMC8220864</ArticleId><ArticleId IdType="pubmed">34171458</ArticleId></ArticleIdList></Reference><Reference><Citation>Giacalone M., Scheier E., Shavit I. Multisystem inflammatory syndrome in children (MIS-C): A mini-review. Int J Emerg Med. 2021;14:50. doi: 10.1186/s12245-021-00373-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12245-021-00373-6</ArticleId><ArticleId IdType="pmc">PMC8432439</ArticleId><ArticleId IdType="pubmed">34507521</ArticleId></ArticleIdList></Reference><Reference><Citation>Hoste L., Van Paemel R., Haerynck F. Multisystem inflammatory syndrome in children related to COVID-19: A systematic review. Eur. J. Pediatr. 2021;180:2019&#x2013;2034. doi: 10.1007/s00431-021-03993-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00431-021-03993-5</ArticleId><ArticleId IdType="pmc">PMC7890544</ArticleId><ArticleId IdType="pubmed">33599835</ArticleId></ArticleIdList></Reference><Reference><Citation>Sananez I., Raiden S.C., Algieri S.C., Uranga M., Grisol&#xed;a N.A., Filippo D., De Carli N., Lalla S.D., Cairoli H., Chiolo M.J., et al. A poor and delayed anti-SARS-CoV2 IgG response is associated to severe COVID-19 in children. EBioMedicine. 2021;72:103615. doi: 10.1016/j.ebiom.2021.103615.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ebiom.2021.103615</ArticleId><ArticleId IdType="pmc">PMC8502533</ArticleId><ArticleId IdType="pubmed">34649078</ArticleId></ArticleIdList></Reference><Reference><Citation>Davies P., Evans C., Kanthimathinathan H.K., Lillie J., Brierley J., Waters G., Johnson M., Griffiths B., du Pr&#xe9; P., Mohammad Z., et al. Intensive care admissions of children with paediatric inflammatory multisystem syndrome temporally associated with SARS-CoV-2 (PIMS-TS) in the UK: A multicentre observational study. Lancet Child Adolesc. Health. 2020;4:669&#x2013;677. doi: 10.1016/S2352-4642(20)30215-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S2352-4642(20)30215-7</ArticleId><ArticleId IdType="pmc">PMC7347350</ArticleId><ArticleId IdType="pubmed">32653054</ArticleId></ArticleIdList></Reference><Reference><Citation>CDC COVID Data Tracker.  [(accessed on 24 October 2021)]; Available online:  https://covid.cdc.gov/covid-data-tracker/#mis-national-surveillance.</Citation></Reference><Reference><Citation>Feldstein L.R., Rose E.B., Horwitz S.M., Collins J.P., Newhams M.M., Son M.B.F., Newburger J.W., Kleinman L.C., Heidemann S.M., Martin A.A., et al. Multisystem inflammatory syndrome in U.S. children and adolescents. N. Engl. J. Med. 2020;383:334&#x2013;346. doi: 10.1056/NEJMoa2021680.</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMoa2021680</ArticleId><ArticleId IdType="pmc">PMC7346765</ArticleId><ArticleId IdType="pubmed">32598831</ArticleId></ArticleIdList></Reference><Reference><Citation>Dufort E.M., Koumans E.H., Chow E.J., Rosenthal E.M., Muse A., Rowlands J., Barranco M.A., Maxted A.M., Rosenberg E.S., Easton D., et al. Multisystem inflammatory syndrome in children in new york state. N. Engl. J. Med. 2020;383:347&#x2013;358. doi: 10.1056/NEJMoa2021756.</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMoa2021756</ArticleId><ArticleId IdType="pmc">PMC7346766</ArticleId><ArticleId IdType="pubmed">32598830</ArticleId></ArticleIdList></Reference><Reference><Citation>Roessler M., Tesch F., Batram M., Jacob J., Loser F., Weidinger O., Wende D., Vivirito A., Toepfner N., Seifert M., et al. Post COVID-19 in children, adolescents, and adults: Results of a matched cohort study including more than 150,000 individuals with COVID-19. medRxiv. 2021 doi: 10.1101/2021.10.21.21265133.</Citation><ArticleIdList><ArticleId IdType="doi">10.1101/2021.10.21.21265133</ArticleId><ArticleId IdType="pmc">PMC9648706</ArticleId><ArticleId IdType="pubmed">36355754</ArticleId></ArticleIdList></Reference><Reference><Citation>What Has Been the Impact of COVID-19 across the UK Countries? The Nuffield Trust.  [(accessed on 31 October 2021)].  Available online:  https://www.nuffieldtrust.org.uk/news-item/what-has-been-the-impact-of-covid-19-across-the-uk-countries?gclid=CjwKCAjw2vOLBhBPEiwAjEeK9kgnV4oYYe8fHM1eOVUEF4SyWRdb7vElgYcO3bAiwjHBId2KAxahwhoCoVEQAvD_BwE.</Citation></Reference><Reference><Citation>Stephenson T., Stephenson T., Pereira S.P., Shafran R., De Stavola B., Rojas N., McOwat K., Simmons R., Zavala M., O&#x2019;Mahoney L., et al. Long COVID&#x2014;The physical and mental health of children and non-hospitalised young people 3 months after SARS-CoV-2 infection; a national matched cohort study (The CLoCk) Study. Res. Sq. 2021;11:e052838. doi: 10.21203/rs.3.rs-798316/v1.</Citation><ArticleIdList><ArticleId IdType="doi">10.21203/rs.3.rs-798316/v1</ArticleId></ArticleIdList></Reference><Reference><Citation>Radtke T., Ulyte A., Puhan M.A., Kriemler S. Long-term Symptoms After SARS-CoV-2 Infection in Children and Adolescents. JAMA. 2021;326:869&#x2013;871. doi: 10.1001/jama.2021.11880.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.2021.11880</ArticleId><ArticleId IdType="pmc">PMC8283661</ArticleId><ArticleId IdType="pubmed">34264266</ArticleId></ArticleIdList></Reference><Reference><Citation>Blankenburg J., Wekenborg M.K., Reichert J., Kirsten C., Kahre E., Haag L., Schumm L., Czyborra P., Berner R., Armann J.P. Mental Health of Adolescents in the Pandemic: Long-COVID-19 or Long-Pandemic Syndrome? SSRN J. 2021 doi: 10.2139/ssrn.3844826.</Citation><ArticleIdList><ArticleId IdType="doi">10.2139/ssrn.3844826</ArticleId></ArticleIdList></Reference><Reference><Citation>Molteni E., Sudre C.H., Canas L.S., Bhopal S.S., Hughes R.C., Antonelli M., Murray B., Kl&#xe4;ser K., Kerfoot E., Chen L., et al. Illness duration and symptom profile in symptomatic UK school-aged children tested for SARS-CoV-2. Lancet Child Adolesc. Health. 2021;5:708&#x2013;718. doi: 10.1016/S2352-4642(21)00198-X.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S2352-4642(21)00198-X</ArticleId><ArticleId IdType="pmc">PMC8443448</ArticleId><ArticleId IdType="pubmed">34358472</ArticleId></ArticleIdList></Reference><Reference><Citation>Osmanov I.M., Spiridonova E., Bobkova P., Gamirova A., Shikhaleva A., Andreeva M., Blyuss O., El-Taravi Y., DunnGalvin A., Comberiati P., et al. Risk factors for long covid in previously hospitalised children using the ISARIC Global follow-up protocol: A prospective cohort study. Eur. Respir. J. 2021 doi: 10.1183/13993003.01341-2021.</Citation><ArticleIdList><ArticleId IdType="doi">10.1183/13993003.01341-2021</ArticleId><ArticleId IdType="pmc">PMC8576804</ArticleId><ArticleId IdType="pubmed">34210789</ArticleId></ArticleIdList></Reference><Reference><Citation>Buonsenso D., Munblit D., De Rose C., Sinatti D., Ricchiuto A., Carfi A., Valentini P. Preliminary Evidence on Long COVID in children. medRxiv. 2021 doi: 10.1111/apa.15870.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/apa.15870</ArticleId><ArticleId IdType="pmc">PMC8251440</ArticleId><ArticleId IdType="pubmed">33835507</ArticleId></ArticleIdList></Reference><Reference><Citation>Miller F., Nguyen V., Navaratnam A.M., Shrotri M., Kovar J., Hayward A.C., Fragaszy E., Aldridge R.W., Hardelid P. Prevalence of persistent symptoms in children during the COVID-19 pandemic: Evidence from a household cohort study in England and Wales. medRxiv. 2021 doi: 10.1101/2021.05.28.21257602.</Citation><ArticleIdList><ArticleId IdType="doi">10.1101/2021.05.28.21257602</ArticleId><ArticleId IdType="pmc">PMC9645448</ArticleId><ArticleId IdType="pubmed">36375098</ArticleId></ArticleIdList></Reference><Reference><Citation>Ashkenazi-Hoffnung L., Shmueli E., Ehrlich S., Ziv A., Bar-On O., Birk E., Lowenthal A., Prais D. Long COVID in children: Observations from A designated pediatric clinic. Pediatr. Infect. Dis. J. 2021;40:e509. doi: 10.1097/INF.0000000000003285.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/INF.0000000000003285</ArticleId><ArticleId IdType="pmc">PMC8575093</ArticleId><ArticleId IdType="pubmed">34371507</ArticleId></ArticleIdList></Reference><Reference><Citation>Prevalence of Ongoing Symptoms Following Coronavirus (COVID-19) Infection in the UK&#x2014;Office for National Statistics.  [(accessed on 31 October 2021)]; Available online:  https://www.ons.gov.uk/peoplepopulationandcommunity/healthandsocialcare/conditionsanddiseases/bulletins/prevalenceofongoingsymptomsfollowingcoronaviruscovid19infectionintheuk/7october2021.</Citation></Reference><Reference><Citation>Results of the Long-COVID Survey Among Children in Israel|Ministry of Health.  [(accessed on 3 November 2021)]; Available online:  https://www.gov.il/en/departments/news/13092021-01.</Citation></Reference><Reference><Citation>Proal A.D., VanElzakker M.B. Long COVID or Post-acute Sequelae of COVID-19 (PASC): An Overview of Biological Factors That May Contribute to Persistent Symptoms. Front. Microbiol. 2021;12:698169. doi: 10.3389/fmicb.2021.698169.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fmicb.2021.698169</ArticleId><ArticleId IdType="pmc">PMC8260991</ArticleId><ArticleId IdType="pubmed">34248921</ArticleId></ArticleIdList></Reference><Reference><Citation>Douaud G., Lee S., Alfaro-Almagro F., Arthofer C., Wang C., Lange F., Andersson J.L.R., Griffanti L., Duff E., Jbabdi S., et al. Brain imaging before and after COVID-19 in UK Biobank. medRxiv. 2021 doi: 10.1101/2021.06.11.21258690.</Citation><ArticleIdList><ArticleId IdType="doi">10.1101/2021.06.11.21258690</ArticleId></ArticleIdList></Reference><Reference><Citation>Wenzel J., Lampe J., M&#xfc;ller-Fielitz H., Schuster R., Zille M., M&#xfc;ller K., Krohn M., K&#xf6;rbelin J., Zhang L., &#xd6;zorhan &#xdc;., et al. The SARS-CoV-2 main protease Mpro causes microvascular brain pathology by cleaving NEMO in brain endothelial cells. Nat. Neurosci. 2021;24:1522&#x2013;1533. doi: 10.1038/s41593-021-00926-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41593-021-00926-1</ArticleId><ArticleId IdType="pmc">PMC8553622</ArticleId><ArticleId IdType="pubmed">34675436</ArticleId></ArticleIdList></Reference><Reference><Citation>Jeong M., Ocwieja K.E., Han D., Wackym P.A., Zhang Y., Brown A., Moncada C., Vambutas A., Kanne T., Crain R., et al. Direct SARS-CoV-2 infection of the human inner ear may underlie COVID-19-associated audiovestibular dysfunction. Commun Med. 2021;1:44. doi: 10.1038/s43856-021-00044-w.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s43856-021-00044-w</ArticleId><ArticleId IdType="pmc">PMC8633908</ArticleId><ArticleId IdType="pubmed">34870285</ArticleId></ArticleIdList></Reference><Reference><Citation>Baggio S., L&#x2019;Huillier A.G., Yerly S., Bellon M., Wagner N., Rohr M., Huttner A., Blanchard-Rohner G., Loevy N., Kaiser L., et al. SARS-CoV-2 viral load in the upper respiratory tract of children and adults with early acute COVID-19. Clin. Infect. Dis. 2020;73:148&#x2013;150. doi: 10.1093/cid/ciaa1157.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/cid/ciaa1157</ArticleId><ArticleId IdType="pmc">PMC7454380</ArticleId><ArticleId IdType="pubmed">32761228</ArticleId></ArticleIdList></Reference><Reference><Citation>Hurst J.H., Heston S.M., Chambers H.N., Cunningham H.M., Price M.J., Suarez L., Crew C.G., Bose S., Aquino J.N., Carr S.T., et al. SARS-CoV-2 Infections Among Children in the Biospecimens from Respiratory Virus-Exposed Kids (BRAVE Kids) Study. Clin. Infect. Dis. 2020 doi: 10.1093/cid/ciaa1693.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/cid/ciaa1693</ArticleId><ArticleId IdType="pmc">PMC7665428</ArticleId><ArticleId IdType="pubmed">33141180</ArticleId></ArticleIdList></Reference><Reference><Citation>Yonker L.M., Neilan A.M., Bartsch Y., Patel A.B., Regan J., Arya P., Gootkind E., Park G., Hardcastle M., St John A., et al. Pediatric Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2): Clinical Presentation, Infectivity, and Immune Responses. J. Pediatr. 2020;227:45&#x2013;52.e5. doi: 10.1016/j.jpeds.2020.08.037.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jpeds.2020.08.037</ArticleId><ArticleId IdType="pmc">PMC7438214</ArticleId><ArticleId IdType="pubmed">32827525</ArticleId></ArticleIdList></Reference><Reference><Citation>Heald-Sargent T., Muller W.J., Zheng X., Rippe J., Patel A.B., Kociolek L.K. Age-Related Differences in Nasopharyngeal Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Levels in Patients With Mild to Moderate Coronavirus Disease 2019 (COVID-19) JAMA Pediatr. 2020;174:902&#x2013;903. doi: 10.1001/jamapediatrics.2020.3651.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamapediatrics.2020.3651</ArticleId><ArticleId IdType="pmc">PMC7393583</ArticleId><ArticleId IdType="pubmed">32745201</ArticleId></ArticleIdList></Reference><Reference><Citation>Li X., Xu W., Dozier M., He Y., Kirolos A., Lang Z., Song P., Theodoratou E. UNCOVER The role of children in the transmission of SARS-CoV2: Updated rapid review. J. Glob. Health. 2020;10:021101. doi: 10.7189/jogh.10.0201101.</Citation><ArticleIdList><ArticleId IdType="doi">10.7189/jogh.10.0201101</ArticleId><ArticleId IdType="pmc">PMC7719356</ArticleId><ArticleId IdType="pubmed">33312511</ArticleId></ArticleIdList></Reference><Reference><Citation>Meyerowitz E.A., Richterman A., Gandhi R.T., Sax P.E. Transmission of SARS-CoV-2: A Review of Viral, Host, and Environmental Factors. Ann. Intern. Med. 2020;174:69&#x2013;79. doi: 10.7326/M20-5008.</Citation><ArticleIdList><ArticleId IdType="doi">10.7326/M20-5008</ArticleId><ArticleId IdType="pmc">PMC7505025</ArticleId><ArticleId IdType="pubmed">32941052</ArticleId></ArticleIdList></Reference><Reference><Citation>Mallapaty S. How do children spread the coronavirus? The science still isn&#x2019;t clear. Nature. 2020;581:127&#x2013;128. doi: 10.1038/d41586-020-01354-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/d41586-020-01354-0</ArticleId><ArticleId IdType="pubmed">32382119</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee B., Raszka W.V. COVID-19 Transmission and Children: The Child Is Not to Blame. Pediatrics. 2020;146 doi: 10.1542/peds.2020-004879.</Citation><ArticleIdList><ArticleId IdType="doi">10.1542/peds.2020-004879</ArticleId><ArticleId IdType="pubmed">32457212</ArticleId></ArticleIdList></Reference><Reference><Citation>COVID-19 in Children in Israel. Israeli Ministry of Health; Jerusalem, Israel: 2020. Director of public health services Ministry of Health COVID-19 in children in Israel; pp. 1&#x2013;24.</Citation></Reference><Reference><Citation>Szablewski C.M., Chang K.T., McDaniel C.J., Chu V.T., Yousaf A.R., Schwartz N.G., Brown M., Winglee K., Paul P., Cui Z., et al. SARS-CoV-2 Transmission Dynamics in a Sleep-Away Camp. Pediatrics. 2021;147:e2020046524. doi: 10.1542/peds.2020-046524.</Citation><ArticleIdList><ArticleId IdType="doi">10.1542/peds.2020-046524</ArticleId><ArticleId IdType="pmc">PMC8982574</ArticleId><ArticleId IdType="pubmed">33504612</ArticleId></ArticleIdList></Reference><Reference><Citation>Pray I.W., Gibbons-Burgener S.N., Rosenberg A.Z., Cole D., Borenstein S., Bateman A., Pevzner E., Westergaard R.P. COVID-19 Outbreak at an Overnight Summer School Retreat&#x2014;Wisconsin, July-August 2020. MMWR Morb. Mortal. Wkly. Rep. 2020;69:1600&#x2013;1604. doi: 10.15585/mmwr.mm6943a4.</Citation><ArticleIdList><ArticleId IdType="doi">10.15585/mmwr.mm6943a4</ArticleId><ArticleId IdType="pmc">PMC7640998</ArticleId><ArticleId IdType="pubmed">33119558</ArticleId></ArticleIdList></Reference><Reference><Citation>Stein-Zamir C., Abramson N., Shoob H., Libal E., Bitan M., Cardash T., Cayam R., Miskin I. A large COVID-19 outbreak in a high school 10 days after schools&#x2019; reopening, Israel, May 2020. Euro Surveill. 2020;25:2001352. doi: 10.2807/1560-7917.ES.2020.25.29.2001352.</Citation><ArticleIdList><ArticleId IdType="doi">10.2807/1560-7917.ES.2020.25.29.2001352</ArticleId><ArticleId IdType="pmc">PMC7384285</ArticleId><ArticleId IdType="pubmed">32720636</ArticleId></ArticleIdList></Reference><Reference><Citation>Goldstein E., Lipsitch M., Cevik M. On the Effect of Age on the Transmission of SARS-CoV-2 in Households, Schools, and the Community. J. Infect. Dis. 2021;223:362&#x2013;369. doi: 10.1093/infdis/jiaa691.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/infdis/jiaa691</ArticleId><ArticleId IdType="pmc">PMC7665686</ArticleId><ArticleId IdType="pubmed">33119738</ArticleId></ArticleIdList></Reference><Reference><Citation>Szablewski C.M., Chang K.T., Brown M.M., Chu V.T., Yousaf A.R., Anyalechi N., Aryee P.A., Kirking H.L., Lumsden M., Mayweather E., et al. SARS-CoV-2 Transmission and Infection Among Attendees of an Overnight Camp&#x2014;Georgia, June 2020. MMWR Morb. Mortal. Wkly. Rep. 2020;69:1023&#x2013;1025. doi: 10.15585/mmwr.mm6931e1.</Citation><ArticleIdList><ArticleId IdType="doi">10.15585/mmwr.mm6931e1</ArticleId><ArticleId IdType="pmc">PMC7454898</ArticleId><ArticleId IdType="pubmed">32759921</ArticleId></ArticleIdList></Reference><Reference><Citation>Park Y.J., Choe Y.J., Park O., Park S.Y., Kim Y.-M., Kim J., Kweon S., Woo Y., Gwack J., Kim S.S., et al. Contact Tracing during Coronavirus Disease Outbreak, South Korea, 2020. Emerg. Infect. Dis. 2020;26:2465&#x2013;2468. doi: 10.3201/eid2610.201315.</Citation><ArticleIdList><ArticleId IdType="doi">10.3201/eid2610.201315</ArticleId><ArticleId IdType="pmc">PMC7510731</ArticleId><ArticleId IdType="pubmed">32673193</ArticleId></ArticleIdList></Reference><Reference><Citation>Posfay-Barbe K.M., Wagner N., Gauthey M., Moussaoui D., Loevy N., Diana A., L&#x2019;Huillier A.G. COVID-19 in Children and the Dynamics of Infection in Families. Pediatrics. 2020;146 doi: 10.1542/peds.2020-1576.</Citation><ArticleIdList><ArticleId IdType="doi">10.1542/peds.2020-1576</ArticleId><ArticleId IdType="pubmed">32457213</ArticleId></ArticleIdList></Reference><Reference><Citation>Kim J., Choe Y.J., Lee J., Park Y.J., Park O., Han M.S., Kim J.-H., Choi E.H. Role of children in household transmission of COVID-19. Arch. Dis. Child. 2021;106:709&#x2013;711. doi: 10.1136/archdischild-2020-319910.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/archdischild-2020-319910</ArticleId><ArticleId IdType="pubmed">32769089</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhu Y., Bloxham C.J., Hulme K.D., Sinclair J.E., Tong Z.W.M., Steele L.E., Noye E.C., Lu J., Xia Y., Chew K.Y., et al. A Meta-analysis on the Role of Children in Severe Acute Respiratory Syndrome Coronavirus 2 in Household Transmission Clusters. Clin. Infect. Dis. 2021;72:e1146&#x2013;e1153. doi: 10.1093/cid/ciaa1825.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/cid/ciaa1825</ArticleId><ArticleId IdType="pmc">PMC7799195</ArticleId><ArticleId IdType="pubmed">33283240</ArticleId></ArticleIdList></Reference><Reference><Citation>Soriano-Arandes A., Gatell A., Serrano P., Biosca M., Campillo F., Capdevila R., F&#xe0;brega A., Lobato Z., L&#xf3;pez N., Moreno A.M., et al. Household severe acute respiratory syndrome coronavirus 2 transmission and children: A network prospective study. Clin. Infect. Dis. 2021;73:e1261&#x2013;e1269. doi: 10.1093/cid/ciab228.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/cid/ciab228</ArticleId><ArticleId IdType="pmc">PMC7989526</ArticleId><ArticleId IdType="pubmed">33709135</ArticleId></ArticleIdList></Reference><Reference><Citation>Pitman-Hunt C., Leja J., Jiwani Z.M., Rondot D., Ang J., Kannikeswaran N. SARS-CoV-2 Transmission in an Urban Community: The Role of Children and Household Contacts. J. Pediatr. Infect. Dis. Soc. 2020;10:919&#x2013;992. doi: 10.1093/jpids/piaa158.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/jpids/piaa158</ArticleId><ArticleId IdType="pmc">PMC7717291</ArticleId><ArticleId IdType="pubmed">33245123</ArticleId></ArticleIdList></Reference><Reference><Citation>Paul L.A., Daneman N., Schwartz K.L., Science M., Brown K.A., Whelan M., Chan E., Buchan S.A. Association of Age and Pediatric Household Transmission of SARS-CoV-2 Infection. JAMA Pediatr. 2021;175:1151&#x2013;1158. doi: 10.1001/jamapediatrics.2021.2770.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamapediatrics.2021.2770</ArticleId><ArticleId IdType="pmc">PMC8369380</ArticleId><ArticleId IdType="pubmed">34398179</ArticleId></ArticleIdList></Reference><Reference><Citation>Chu V.T., Yousaf A.R., Chang K., Schwartz N.G., McDaniel C.J., Lee S.H., Szablewski C.M., Brown M., Drenzek C.L., Dirlikov E., et al. Household Transmission of SARS-CoV-2 from Children and Adolescents. N. Engl. J. Med. 2021;385:954&#x2013;956. doi: 10.1056/NEJMc2031915.</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMc2031915</ArticleId><ArticleId IdType="pmc">PMC8314736</ArticleId><ArticleId IdType="pubmed">34289272</ArticleId></ArticleIdList></Reference><Reference><Citation>Grijalva C.G., Rolfes M.A., Zhu Y., McLean H.Q., Hanson K.E., Belongia E.A., Halasa N.B., Kim A., Reed C., Fry A.M., et al. Transmission of SARS-COV-2 Infections in Households&#x2014;Tennessee and Wisconsin, April-September 2020. MMWR Morb. Mortal. Wkly. Rep. 2020;69:1631&#x2013;1634. doi: 10.15585/mmwr.mm6944e1.</Citation><ArticleIdList><ArticleId IdType="doi">10.15585/mmwr.mm6944e1</ArticleId><ArticleId IdType="pmc">PMC7643897</ArticleId><ArticleId IdType="pubmed">33151916</ArticleId></ArticleIdList></Reference><Reference><Citation>Coffin S.E., Rubin D. Yes, children can transmit COVID, but we need not fear. JAMA Pediatr. 2021;175:1110. doi: 10.1001/jamapediatrics.2021.2767.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamapediatrics.2021.2767</ArticleId><ArticleId IdType="pubmed">34398229</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee B., Raszka W.V. COVID-19 in Children: Looking Forward, Not Back. Pediatrics. 2021;147 doi: 10.1542/peds.2020-029736.</Citation><ArticleIdList><ArticleId IdType="doi">10.1542/peds.2020-029736</ArticleId><ArticleId IdType="pubmed">33033179</ArticleId></ArticleIdList></Reference><Reference><Citation>Hobbs C.V., Martin L.M., Kim S.S., Kirmse B.M., Haynie L., McGraw S., Byers P., Taylor K.G., Patel M.M., Flannery B., et al. Factors Associated with Positive SARS-CoV-2 Test Results in Outpatient Health Facilities and Emergency Departments Among Children and Adolescents Aged &lt;18 Years&#x2014;Mississippi, September-November 2020. MMWR Morb. Mortal. Wkly. Rep. 2020;69:1925&#x2013;1929. doi: 10.15585/mmwr.mm6950e3.</Citation><ArticleIdList><ArticleId IdType="doi">10.15585/mmwr.mm6950e3</ArticleId><ArticleId IdType="pmc">PMC7745952</ArticleId><ArticleId IdType="pubmed">33332298</ArticleId></ArticleIdList></Reference><Reference><Citation>Lopez A.S., Hill M., Antezano J., Vilven D., Rutner T., Bogdanow L., Claflin C., Kracalik I.T., Fields V.L., Dunn A., et al. Transmission Dynamics of COVID-19 Outbreaks Associated with Child Care Facilities&#x2014;Salt Lake City, Utah, April-July 2020. MMWR Morb. Mortal. Wkly. Rep. 2020;69:1319&#x2013;1323. doi: 10.15585/mmwr.mm6937e3.</Citation><ArticleIdList><ArticleId IdType="doi">10.15585/mmwr.mm6937e3</ArticleId><ArticleId IdType="pmc">PMC7498176</ArticleId><ArticleId IdType="pubmed">32941418</ArticleId></ArticleIdList></Reference><Reference><Citation>Danis K., Epaulard O., B&#xe9;net T., Gaymard A., Campoy S., Botelho-Nevers E., Bouscambert-Duchamp M., Spaccaferri G., Ader F., Mailles A., et al. Cluster of Coronavirus Disease 2019 (COVID-19) in the French Alps, February 2020. Clin. Infect. Dis. 2020;71:825&#x2013;832. doi: 10.1093/cid/ciaa424.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/cid/ciaa424</ArticleId><ArticleId IdType="pmc">PMC7184384</ArticleId><ArticleId IdType="pubmed">32277759</ArticleId></ArticleIdList></Reference><Reference><Citation>Heavey L., Casey G., Kelly C., Kelly D., McDarby G. No evidence of secondary transmission of COVID-19 from children attending school in Ireland, 2020. Euro Surveill. 2020;25:2000903. doi: 10.2807/1560-7917.ES.2020.25.21.2000903.</Citation><ArticleIdList><ArticleId IdType="doi">10.2807/1560-7917.ES.2020.25.21.2000903</ArticleId><ArticleId IdType="pmc">PMC7268273</ArticleId><ArticleId IdType="pubmed">32489179</ArticleId></ArticleIdList></Reference><Reference><Citation>Ehrhardt J., Ekinci A., Krehl H., Meincke M., Finci I., Klein J., Geisel B., Wagner-Wiening C., Eichner M., Brockmann S.O. Transmission of SARS-CoV-2 in children aged 0 to 19 years in childcare facilities and schools after their reopening in May 2020, Baden-W&#xfc;rttemberg, Germany. Euro Surveill. 2020;25:2001587. doi: 10.2807/1560-7917.ES.2020.25.36.2001587.</Citation><ArticleIdList><ArticleId IdType="doi">10.2807/1560-7917.ES.2020.25.36.2001587</ArticleId><ArticleId IdType="pmc">PMC7502898</ArticleId><ArticleId IdType="pubmed">32914746</ArticleId></ArticleIdList></Reference><Reference><Citation>Link-Gelles R., DellaGrotta A.L., Molina C., Clyne A., Campagna K., Lanzieri T.M., Hast M.A., Palipudi K., Dirlikov E., Bandy U. Limited Secondary Transmission of SARS-CoV-2 in Child Care Programs&#x2014;Rhode Island, June 1-July 31, 2020. MMWR Morb. Mortal. Wkly. Rep. 2020;69:1170&#x2013;1172. doi: 10.15585/mmwr.mm6934e2.</Citation><ArticleIdList><ArticleId IdType="doi">10.15585/mmwr.mm6934e2</ArticleId><ArticleId IdType="pmc">PMC7451972</ArticleId><ArticleId IdType="pubmed">32853185</ArticleId></ArticleIdList></Reference><Reference><Citation>Yung C.F., Kam K.-Q., Nadua K.D., Chong C.Y., Tan N.W.H., Li J., Lee K.P., Chan Y.H., Thoon K.C., Ng K.C. Novel coronavirus 2019 transmission risk in educational settings. Clin. Infect. Dis. 2021;72:1055&#x2013;1058. doi: 10.1093/cid/ciaa794.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/cid/ciaa794</ArticleId><ArticleId IdType="pmc">PMC7337629</ArticleId><ArticleId IdType="pubmed">32584975</ArticleId></ArticleIdList></Reference><Reference><Citation>Yoon Y., Choi G.-J., Kim J.Y., Kim K.-R., Park H., Chun J.K., Kim Y.-J. Childcare Exposure to Severe Acute Respiratory Syndrome Coronavirus 2 for 4-Year-Old Presymptomatic Child, South Korea. Emerg. Infect. Dis. 2021;27:341&#x2013;347. doi: 10.3201/eid2702.203189.</Citation><ArticleIdList><ArticleId IdType="doi">10.3201/eid2702.203189</ArticleId><ArticleId IdType="pmc">PMC7853589</ArticleId><ArticleId IdType="pubmed">33252327</ArticleId></ArticleIdList></Reference><Reference><Citation>Kim C., McGee S., Khuntia S., Elnour A., Johnson-Clarke F., Mangla A., Iyengar P., Nesbitt L. Characteristics of COVID-19 Cases and Outbreaks at Child Care Facilities&#x2014;District of Columbia, July-December 2020. MMWR Morb. Mortal. Wkly. Rep. 2021;70:744&#x2013;748. doi: 10.15585/mmwr.mm7020a3.</Citation><ArticleIdList><ArticleId IdType="doi">10.15585/mmwr.mm7020a3</ArticleId><ArticleId IdType="pmc">PMC8136421</ArticleId><ArticleId IdType="pubmed">34014908</ArticleId></ArticleIdList></Reference><Reference><Citation>van Loon W., Hommes F., Theuring S., von der Haar A., K&#xf6;rner J., Schmidt M., von Kalle C., Mall M.A., Seybold J., Kurth T., et al. Renewed Absence of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Infections in the Day Care Context in Berlin, January 2021. Clin. Infect. Dis. 2021;73:1944&#x2013;1945. doi: 10.1093/cid/ciab199.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/cid/ciab199</ArticleId><ArticleId IdType="pmc">PMC7989586</ArticleId><ArticleId IdType="pubmed">33675648</ArticleId></ArticleIdList></Reference><Reference><Citation>Lachassinne E., de Pontual L., Caseris M., Lorrot M., Guilluy C., Naud A., Dommergues M.-A., Pinquier D., Wannepain E., Hausherr E., et al. SARS-CoV-2 transmission among children and staff in daycare centres during a nationwide lockdown in France: A cross-sectional, multicentre, seroprevalence study. Lancet Child Adolesc. Health. 2021;5:256&#x2013;264. doi: 10.1016/S2352-4642(21)00024-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S2352-4642(21)00024-9</ArticleId><ArticleId IdType="pmc">PMC9180428</ArticleId><ArticleId IdType="pubmed">33571450</ArticleId></ArticleIdList></Reference><Reference><Citation>Bourion-B&#xe9;d&#xe8;s S., Tarquinio C., Batt M., Tarquinio P., Lebreuilly R., Sorsana C., Legrand K., Rousseau H., Baumann C. Psychological impact of the COVID-19 outbreak on students in a French region severely affected by the disease: Results of the PIMS-CoV 19 study. Psychiatry Res. 2021;295:113559. doi: 10.1016/j.psychres.2020.113559.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.psychres.2020.113559</ArticleId><ArticleId IdType="pmc">PMC7644189</ArticleId><ArticleId IdType="pubmed">33189368</ArticleId></ArticleIdList></Reference><Reference><Citation>de Figueiredo C.S., Sandre P.C., Portugal L.C.L., M&#xe1;zala-de-Oliveira T., da Silva Chagas L., Raony &#xcd;., Ferreira E.S., Giestal-de-Araujo E., Dos Santos A.A., Bomfim P.O.-S. COVID-19 pandemic impact on children and adolescents&#x2019; mental health: Biological, environmental, and social factors. Prog. Neuropsychopharmacol. Biol. Psychiatry. 2021;106:110171. doi: 10.1016/j.pnpbp.2020.110171.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.pnpbp.2020.110171</ArticleId><ArticleId IdType="pmc">PMC7657035</ArticleId><ArticleId IdType="pubmed">33186638</ArticleId></ArticleIdList></Reference><Reference><Citation>Taub Center Opportunities and Risks to the Education System in the Time of the Coronavirus an Overview.  [(accessed on 11 April 2021)].  Available online:  http://taubcenter.org.il/he/opportunities-and-risks-to-the-education-system-in-the-time-of-the-coronavirus-an-overview/</Citation></Reference><Reference><Citation>Central Bureau of Statistics Civil Resilience During the Coronavirus Crisis Among Persons Aged 21 and Over.  [(accessed on 11 April 2021)]; Available online:  https://www.cbs.gov.il/he/mediarelease/Pages/2020/%D7%AA%D7%9E%D7%95%D7%A0%D7%AA-%D7%9E%D7%A6%D7%91-%D7%A9%D7%9C-%D7%94%D7%97%D7%95%D7%A1%D7%9F-%D7%94%D7%90%D7%96%D7%A8%D7%97%D7%99-%D7%91%D7%AA%D7%A7%D7%95%D7%A4%D7%AA-%D7%9E%D7%A9%D7%91%D7%A8-%D7%94%D7%A7%D7%95%D7%A8%D7%95%D7%A0%D7%94.aspx.</Citation></Reference><Reference><Citation>Bank of Israel Bank of Israel Periodical Report.  [(accessed on 11 April 2021)].  Available online:  https://www.boi.org.il/he/NewsAndPublications/RegularPublications/Pages/DochBankIsrael2020.aspx.</Citation></Reference><Reference><Citation>Lopez Bernal J., Andrews N., Gower C., Gallagher E., Simmons R., Thelwall S., Tessier E., Groves N., Dabrera G., Myers R., et al. Effectiveness of COVID-19 vaccines against the B.1.617.2 variant. medRxiv. 2021 doi: 10.1056/NEJMoa2108891.</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMoa2108891</ArticleId><ArticleId IdType="pmc">PMC8314739</ArticleId><ArticleId IdType="pubmed">34289274</ArticleId></ArticleIdList></Reference><Reference><Citation>FDA . EUA Amendment Request for Pfizer-BioNTech COVID-19 Vaccine for Use in Children 5 through 11 Years of Age. FDA; Silver Spring, MD, USA: 2021.</Citation></Reference><Reference><Citation>Polack F.P., Thomas S.J., Kitchin N., Absalon J., Gurtman A., Lockhart S., Perez J.L., P&#xe9;rez Marc G., Moreira E.D., Zerbini C., et al. Safety and Efficacy of the BNT162b2 mRNA Covid-19 Vaccine. N. Engl. J. Med. 2020;383:2603&#x2013;2615. doi: 10.1056/NEJMoa2034577.</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMoa2034577</ArticleId><ArticleId IdType="pmc">PMC7745181</ArticleId><ArticleId IdType="pubmed">33301246</ArticleId></ArticleIdList></Reference><Reference><Citation>Haas E.J., Angulo F.J., McLaughlin J.M., Anis E., Singer S.R., Khan F., Brooks N., Smaja M., Mircus G., Pan K., et al.  Nationwide Vaccination Campaign with BNT162b2 in Israel Demonstrates High Vaccine Effectiveness and Marked Declines in Incidence of SARS-CoV-2 Infections and COVID-19 Cases, Hospitalizations, and Deaths. 2021.  [(accessed on 29 December 2021)].  Available online:  https://ssrn.com/abstract=3811387.</Citation></Reference><Reference><Citation>Dagan N., Barda N., Kepten E., Miron O., Perchik S., Katz M.A., Hern&#xe1;n M.A., Lipsitch M., Reis B., Balicer R.D. BNT162b2 mRNA Covid-19 Vaccine in a Nationwide Mass Vaccination Setting. N. Engl. J. Med. 2021;384:1412&#x2013;1423. doi: 10.1056/NEJMoa2101765.</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMoa2101765</ArticleId><ArticleId IdType="pmc">PMC7944975</ArticleId><ArticleId IdType="pubmed">33626250</ArticleId></ArticleIdList></Reference><Reference><Citation>Frenck R.W., Klein N.P., Kitchin N., Gurtman A., Absalon J., Lockhart S., Perez J.L., Walter E.B., Senders S., Bailey R., et al. Safety, Immunogenicity, and Efficacy of the BNT162b2 Covid-19 Vaccine in Adolescents. N. Engl. J. Med. 2021;385:239&#x2013;250. doi: 10.1056/NEJMoa2107456.</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMoa2107456</ArticleId><ArticleId IdType="pmc">PMC8174030</ArticleId><ArticleId IdType="pubmed">34043894</ArticleId></ArticleIdList></Reference><Reference><Citation>Olson S.M., Newhams M.M., Halasa N.B., Price A.M., Boom J.A., Sahni L.C., Irby K., Walker T.C., Schwartz S.P., Pannaraj P.S., et al. Effectiveness of Pfizer-BioNTech mRNA Vaccination Against COVID-19 Hospitalization Among Persons Aged 12-18 Years&#x2014;United States, June-September 2021. MMWR Morb. Mortal. Wkly. Rep. 2021;70:1483&#x2013;1488. doi: 10.15585/mmwr.mm7042e1.</Citation><ArticleIdList><ArticleId IdType="doi">10.15585/mmwr.mm7042e1</ArticleId><ArticleId IdType="pmc">PMC9361838</ArticleId><ArticleId IdType="pubmed">34673751</ArticleId></ArticleIdList></Reference><Reference><Citation>Tang L., Hijano D.R., Gaur A.H., Geiger T.L., Neufeld E.J., Hoffman J.M., Hayden R.T. Asymptomatic and Symptomatic SARS-CoV-2 Infections After BNT162b2 Vaccination in a Routinely Screened Workforce. JAMA. 2021;325:2500&#x2013;2502. doi: 10.1001/jama.2021.6564.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.2021.6564</ArticleId><ArticleId IdType="pmc">PMC8220512</ArticleId><ArticleId IdType="pubmed">33956050</ArticleId></ArticleIdList></Reference><Reference><Citation>Lumley S.F., Rodger G., Constantinides B., Sanderson N., Chau K.K., Street T.L., O&#x2019;Donnell D., Howarth A., Hatch S.B., Marsden B.D., et al. An observational cohort study on the incidence of SARS-CoV-2 infection and B.1.1.7 variant infection in healthcare workers by antibody and vaccination status. Clin. Infect. Dis. 2021 doi: 10.1093/cid/ciab608.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/cid/ciab608</ArticleId><ArticleId IdType="pmc">PMC8994591</ArticleId><ArticleId IdType="pubmed">34216472</ArticleId></ArticleIdList></Reference><Reference><Citation>Andrejko K.L., Pry J., Myers J.F., Jewell N.P., Openshaw J., Watt J., Jain S., Lewnard J.A. California COVID-19 Case-Control Study Team Prevention of COVID-19 by mRNA-based vaccines within the general population of California. Clin. Infect. Dis. 2021 doi: 10.1093/cid/ciab640.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/cid/ciab640</ArticleId><ArticleId IdType="pmc">PMC8406879</ArticleId><ArticleId IdType="pubmed">34282839</ArticleId></ArticleIdList></Reference><Reference><Citation>Pouwels K.B., Pritchard E., Matthews P.C., Stoesser N., Eyre D.W., Vihta K.-D., House T., Hay J., Bell J.I., Newton J.N., et al. Effect of Delta variant on viral burden and vaccine effectiveness against new SARS-CoV-2 infections in the UK. Nat. Med. 2021:2127&#x2013;2135. doi: 10.1038/s41591-021-01548-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41591-021-01548-7</ArticleId><ArticleId IdType="pmc">PMC8674129</ArticleId><ArticleId IdType="pubmed">34650248</ArticleId></ArticleIdList></Reference><Reference><Citation>Elliott P., Haw D., Wang H., Eales O., Walters C.E., Ainslie K.E.C., Atchison C., Fronterre C., Diggle P.J., Page A.J., et al. REACT-1 round 13 final report: Exponential growth, high prevalence of SARS-CoV-2 and vaccine effectiveness associated with Delta variant in England during May to July 2021. medRxiv. 2021 doi: 10.1101/2021.09.02.21262979.</Citation><ArticleIdList><ArticleId IdType="doi">10.1101/2021.09.02.21262979</ArticleId><ArticleId IdType="pmc">PMC10763627</ArticleId><ArticleId IdType="pubmed">34726481</ArticleId></ArticleIdList></Reference><Reference><Citation>Reis B.Y., Barda N., Leshchinsky M., Kepten E., Hern&#xe1;n M.A., Lipsitch M., Dagan N., Balicer R.D. Effectiveness of BNT162b2 Vaccine against Delta Variant in Adolescents. N. Engl. J. Med. 2021;385:2101&#x2013;2103. doi: 10.1056/NEJMc2114290.</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMc2114290</ArticleId><ArticleId IdType="pmc">PMC8552532</ArticleId><ArticleId IdType="pubmed">34670036</ArticleId></ArticleIdList></Reference><Reference><Citation>Eyre D.W., Taylor D., Purver M., Chapman D., Fowler T., Pouwels K., Walker A.S., Peto T.E. The impact of SARS-CoV-2 vaccination on Alpha and Delta variant transmission. medRxiv. 2021 doi: 10.1101/2021.09.28.21264260.</Citation><ArticleIdList><ArticleId IdType="doi">10.1101/2021.09.28.21264260</ArticleId><ArticleId IdType="pmc">PMC8757571</ArticleId><ArticleId IdType="pubmed">34986294</ArticleId></ArticleIdList></Reference><Reference><Citation>Chia P.Y., Ong S., Chiew C.J., Ang L.W., Chavatte J.G., Mak T.M., Cui L., Kalimuddin S., Chia W.N., Tan C.W., et al. Virological and serological kinetics of SARS-CoV-2 Delta variant vaccine-breakthrough infections: A multi-center cohort study. medRxiv. 2021 doi: 10.1101/2021.07.28.21261295.</Citation><ArticleIdList><ArticleId IdType="doi">10.1101/2021.07.28.21261295</ArticleId><ArticleId IdType="pmc">PMC8608661</ArticleId><ArticleId IdType="pubmed">34826623</ArticleId></ArticleIdList></Reference><Reference><Citation>Singanayagam A., Hakki S., Dunning J., Madon K.J., Crone M.A., Koycheva A., Derqui-Fernandez N., Barnett J.L., Whitfield M.G., Varro R., et al. Community transmission and viral load kinetics of the SARS-CoV-2 delta (B.1.617.2) variant in vaccinated and unvaccinated individuals in the UK: A prospective, longitudinal, cohort study. Lancet Infect. Dis. 2021 doi: 10.1016/S1473-3099(21)00648-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1473-3099(21)00648-4</ArticleId><ArticleId IdType="pmc">PMC8554486</ArticleId><ArticleId IdType="pubmed">34756186</ArticleId></ArticleIdList></Reference><Reference><Citation>Allen H., Vusirikala A., Flannagan J., Twohig K.A., Zaidi A., Chudasama D., Lamagni T., Groves N., Turner C., Rawlinson C., et al. Household transmission of COVID-19 cases associated with SARS-CoV-2 delta variant (B.1.617.2): National case-control study. Lancet Reg. Health Eur. 2022;12:100252. doi: 10.1016/j.lanepe.2021.100252.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.lanepe.2021.100252</ArticleId><ArticleId IdType="pmc">PMC8552812</ArticleId><ArticleId IdType="pubmed">34729548</ArticleId></ArticleIdList></Reference><Reference><Citation>de Gier B., Andeweg S., Backer J.A., RIVM COVID-19 surveillance and epidemiology team. Hahn&#xe9; S.J.M., van den Hof S., de Melker H.E., Knol M.J. Vaccine effectiveness against SARS-CoV-2 transmission to household contacts during dominance of Delta variant (B.1.617.2), August-September 2021, the Netherlands. medRxiv. 2021 September 20; doi: 10.2807/1560-7917.ES.2021.26.44.2100977.</Citation><ArticleIdList><ArticleId IdType="doi">10.2807/1560-7917.ES.2021.26.44.2100977</ArticleId><ArticleId IdType="pmc">PMC8569927</ArticleId><ArticleId IdType="pubmed">34738514</ArticleId></ArticleIdList></Reference><Reference><Citation>Strategy to Achieve Global Covid-19 Vaccination by mid-2022&#x2014;World|ReliefWeb.  [(accessed on 18 December 2021)].  Available online:  https://reliefweb.int/report/world/strategy-achieve-global-covid-19-vaccination-mid-2022.</Citation></Reference><Reference><Citation>SARS-CoV-2 Variants of Concern as of 16 December 2021.  [(accessed on 18 December 2021)].  Available online:  https://www.ecdc.europa.eu/en/covid-19/variants-concern.</Citation></Reference><Reference><Citation>Tracking SARS-CoV-2 Variants.  [(accessed on 18 December 2021)].  Available online:  https://www.who.int/en/activities/tracking-SARS-CoV-2-variants/</Citation></Reference><Reference><Citation>Classification of Omicron (B.1.1.529): SARS-CoV-2 Variant of Concern.  [(accessed on 18 December 2021)].  Available online:  https://www.who.int/news/item/26-11-2021-classification-of-omicron-(b.1.1.529)-sars-cov-2-variant-of-concern.</Citation></Reference><Reference><Citation>WHO Director-General&#x2019;s Opening Remarks at the Media Briefing on COVID-19&#x2014;14 December 2021.  [(accessed on 18 December 2021)].  Available online:  https://www.who.int/director-general/speeches/detail/who-director-general-s-opening-remarks-at-the-media-briefing-on-covid-19---14-december-2021.</Citation></Reference><Reference><Citation>Gardner B.J., Kilpatrick A.M. Estimates of reduced vaccine effectiveness against hospitalization, infection, transmission and symptomatic disease of a new SARS-CoV-2 variant, Omicron (B.1.1.529), using neutralizing antibody titers. medRxiv. 2021 doi: 10.1101/2021.12.10.21267594.</Citation><ArticleIdList><ArticleId IdType="doi">10.1101/2021.12.10.21267594</ArticleId></ArticleIdList></Reference><Reference><Citation>Pfizer and BioNTech Provide Update on Omicron Variant|Business Wire.  [(accessed on 18 December 2021)].  Available online:  https://www.businesswire.com/news/home/20211208005542/en/Pfizer-and-BioNTech-Provide-Update-on-Omicron-Variant.</Citation></Reference><Reference><Citation>Wilhelm A., Widera M., Grikscheit K., Toptan T., Schenk B., Pallas C., Metzler M., Kohmer N., Hoehl S., Helfritz F.A., et al. Reduced Neutralization of SARS-CoV-2 Omicron Variant by Vaccine Sera and monoclonal antibodies. medRxiv. 2021 doi: 10.1101/2021.12.07.21267432.</Citation><ArticleIdList><ArticleId IdType="doi">10.1101/2021.12.07.21267432</ArticleId></ArticleIdList></Reference><Reference><Citation>Tuite A.R., Zhu L., Fisman D.N., Salomon J.A. Alternative Dose Allocation Strategies to Increase Benefits From Constrained COVID-19 Vaccine Supply. Ann. Intern. Med. 2021;174:570&#x2013;572. doi: 10.7326/M20-8137.</Citation><ArticleIdList><ArticleId IdType="doi">10.7326/M20-8137</ArticleId><ArticleId IdType="pmc">PMC7808325</ArticleId><ArticleId IdType="pubmed">33395334</ArticleId></ArticleIdList></Reference><Reference><Citation>Overview of the Implementation of COVID-19 Vaccination Strategies and Deployment Plans in the EU/EEA.  [(accessed on 18 December 2021)].  Available online:  https://www.ecdc.europa.eu/en/publications-data/overview-implementation-covid-19-vaccination-strategies-and-deployment-plans.</Citation></Reference><Reference><Citation>UK to Offer Booster Shots to All Adults, Just 3 Months after Their Second Dose&#x2014;CNN.  [(accessed on 19 December 2021)].  Available online:  https://edition.cnn.com/2021/11/29/uk/uk-booster-vaccine-expansion-omicron-gbr-intl/index.html.</Citation></Reference><Reference><Citation>France Brings forward Third COVID-19 Vaccine Shot|Reuters.  [(accessed on 19 December 2021)].  Available online:  https://www.reuters.com/world/europe/france-reduces-delay-get-third-covid-19-booster-shot-four-months-2021-12-17/</Citation></Reference><Reference><Citation>S.Korea to Cut COVID-19 Booster Shot Interval Again as Infections Rise Reuters.  [(accessed on 19 December 2021)].  Available online:  https://www.reuters.com/world/asia-pacific/skorea-cut-covid-19-booster-shot-interval-again-infections-rise-2021-12-10/</Citation></Reference><Reference><Citation>Denmark Cuts Interval Between Covid Second Dose and Booster Shot To 4.5 Months.  [(accessed on 19 December 2021)].  Available online:  https://www.ndtv.com/world-news/denmark-cuts-covid-19-booster-shot-interval-to-4-5-months-2648932.</Citation></Reference><Reference><Citation>Andrews N., Stowe J., Kirsebom F., Toffa S., Rickeard T., Gallagher E., Gower C., Kall M., Groves N., O&#x2019;Connell A.-M., et al. Effectiveness of COVID-19 vaccines against the Omicron (B.1.1.529) variant of concern. medRxiv. 2021 doi: 10.1101/2021.12.14.21267615.</Citation><ArticleIdList><ArticleId IdType="doi">10.1101/2021.12.14.21267615</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang X., Powell C.A. How to translate the knowledge of COVID-19 into prevention of Omicron variants. Clin. Transl. Discov. 2021;1 doi: 10.1002/ctd2.22.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/ctd2.22</ArticleId><ArticleId IdType="pmc">PMC8666580</ArticleId><ArticleId IdType="pubmed">34898050</ArticleId></ArticleIdList></Reference><Reference><Citation>Antonelli M., Penfold R.S., Merino J., Sudre C.H., Molteni E., Berry S., Canas L.S., Graham M.S., Klaser K., Modat M., et al. Risk factors and disease profile of post-vaccination SARS-CoV-2 infection in UK users of the COVID Symptom Study app: A prospective, community-based, nested, case-control study. Lancet Infect. Dis. 2021 doi: 10.1016/S1473-3099(21)00460-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1473-3099(21)00460-6</ArticleId><ArticleId IdType="pmc">PMC8409907</ArticleId><ArticleId IdType="pubmed">34480857</ArticleId></ArticleIdList></Reference><Reference><Citation>Wallace M. COVID19 mRNA vaccines in adolescents and young adults: Benefitrisk discussion 2021; Proceedings of the ACIP Meeting; online. 23 June 2021.</Citation></Reference><Reference><Citation>CDC Encourages Vaccination of Children to Prevent MIS-C, a Rare Illness Linked to Coronavirus|Health News|US News.  [(accessed on 1 November 2021)].  Available online:  https://www.usnews.com/news/health-news/articles/2021-06-17/cdc-encourages-vaccination-of-children-to-prevent-mis-c-a-rare-illness-linked-to-coronavirus.</Citation></Reference><Reference><Citation>Coronavirus (COVID-19) Update: FDA Authorizes Pfizer-BioNTech COVID-19 Vaccine for Emergency Use in Adolescents in Another Important Action in Fight Against Pandemic|FDA.  [(accessed on 3 June 2021)]; Available online:  https://www.fda.gov/news-events/press-announcements/coronavirus-covid-19-update-fda-authorizes-pfizer-biontech-covid-19-vaccine-emergency-use.</Citation></Reference><Reference><Citation>The MHRA Concludes Positive Safety Profile for Pfizer/BioNTech Vaccine in 12- to 15-Year-Olds&#x2014;GOV.UK.  [(accessed on 5 June 2021)]; Available online:  https://www.gov.uk/government/news/the-mhra-concludes-positive-safety-profile-for-pfizerbiontech-vaccine-in-12-to-15-year-olds.</Citation></Reference><Reference><Citation>First COVID-19 Vaccine Approved for Children Aged 12 to 15 in EU|European Medicines Agency.  [(accessed on 5 June 2021)].  Available online:  https://www.ema.europa.eu/en/news/first-covid-19-vaccine-approved-children-aged-12-15-eu.</Citation></Reference><Reference><Citation>GRADE: Pfizer-BioNTech COVID-19 Vaccine Age 12&#x2013;15 Years|CDC.  [(accessed on 3 June 2021)]; Available online:  https://www.cdc.gov/vaccines/acip/recs/grade/covid-19-pfizer-biontech-vaccine-12-15-years.html.</Citation></Reference><Reference><Citation>Tom Shimabukuro Advisory Committee on Immunization Practices (ACIP) Safty Updates 23 June 2021.  [(accessed on 23 June 2021)]; Available online:  https://www.cdc.gov/vaccines/acip/meetings/downloads/slides-2021-10-20-21/06-COVID-Shimabukuro-508.pdf.</Citation></Reference><Reference><Citation>Interim Statement on COVID-19 Vaccination for Children and Adolescents.  [(accessed on 21 December 2021)].  Available online:  https://www.who.int/news/item/24-11-2021-interim-statement-on-covid-19-vaccination-for-children-and-adolescents.</Citation></Reference><Reference><Citation>National Advisory Committee on Immunization National Advisory Committee on Immunization (NACI) Statement: Recommendation on the Use of the Pfizer-BioNTech COVID-19 Vaccine (10 mcg) in Children 5 to 11 Years of Age.  [(accessed on 21 December 2021)].  Available online:  https://www.canada.ca/en/public-health/services/immunization/national-advisory-committee-on-immunization-naci/recommendations-use-covid-19-vaccines/pfizer-biontech-10-mcg-children-5-11-years-age.html.</Citation></Reference><Reference><Citation>European Centre for Disease Prevention and Control . Interim Public Health Considerations for COVID-19 Vaccination of Children Aged 5-11 Years. ECDC; Stockholm, Swedish: 2021.</Citation></Reference><Reference><Citation>Mevorach D., Anis E., Cedar N., Bromberg M., Haas E.J., Nadir E., Olsha-Castell S., Arad D., Hasin T., Levi N., et al. Myocarditis after BNT162b2 mRNA Vaccine against Covid-19 in Israel. N. Engl. J. Med. 2021;385:2140&#x2013;2149. doi: 10.1056/NEJMoa2109730.</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMoa2109730</ArticleId><ArticleId IdType="pmc">PMC8531987</ArticleId><ArticleId IdType="pubmed">34614328</ArticleId></ArticleIdList></Reference><Reference><Citation>Israel Ministry of Health . Summary of Corona Myocarditis Events Following the COVID Vaccine, December 2020&#x2013;May 2021. Israel Ministry of Health; Jerusalem, Israel: 2021. pp. 1&#x2013;16.</Citation></Reference><Reference><Citation>Vaccines and Related Biological Products Advisory Committee June 10, 2021 Meeting Presentation.  [(accessed on 10 June 2021)]; Available online:  https://www.fda.gov/media/149935/download.</Citation></Reference><Reference><Citation>Bozkurt B., Kamat I., Hotez P.J. Myocarditis With COVID-19 mRNA Vaccines. Circulation. 2021;144:471&#x2013;484. doi: 10.1161/CIRCULATIONAHA.121.056135.</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/CIRCULATIONAHA.121.056135</ArticleId><ArticleId IdType="pmc">PMC8340726</ArticleId><ArticleId IdType="pubmed">34281357</ArticleId></ArticleIdList></Reference><Reference><Citation>Singer M.E., Taub I.B., Kaelber D.C. Risk of Myocarditis from COVID-19 Infection in People Under Age 20: A Population-Based Analysis. medRxiv. 2021 doi: 10.1101/2021.07.23.21260998.</Citation><ArticleIdList><ArticleId IdType="doi">10.1101/2021.07.23.21260998</ArticleId></ArticleIdList></Reference><Reference><Citation>Barda N., Dagan N., Ben-Shlomo Y., Kepten E., Waxman J., Ohana R., Hern&#xe1;n M.A., Lipsitch M., Kohane I., Netzer D., et al. Safety of the BNT162b2 mRNA Covid-19 Vaccine in a Nationwide Setting. N. Engl. J. Med. 2021;385:1078&#x2013;1090. doi: 10.1056/NEJMoa2110475.</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMoa2110475</ArticleId><ArticleId IdType="pmc">PMC8427535</ArticleId><ArticleId IdType="pubmed">34432976</ArticleId></ArticleIdList></Reference><Reference><Citation>Dagan N., Barda N., Balicer R.D. Adverse Effects after BNT162b2 Vaccine and SARS-CoV-2 Infection, According to Age and Sex. N. Engl. J. Med. 2021;385:2299. doi: 10.1056/NEJMc2115045.</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMc2115045</ArticleId><ArticleId IdType="pmc">PMC8609601</ArticleId><ArticleId IdType="pubmed">34706169</ArticleId></ArticleIdList></Reference><Reference><Citation>Vasudeva R., Bhatt P., Lilje C., Desai P., Amponsah J., Umscheid J., Parmar N., Bhatt N., Adupa R., Pagad S., et al. Trends in Acute Myocarditis Related Pediatric Hospitalizations in the United States, 2007-2016. Am. J. Cardiol. 2021;149:95&#x2013;102. doi: 10.1016/j.amjcard.2021.03.019.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.amjcard.2021.03.019</ArticleId><ArticleId IdType="pubmed">33757784</ArticleId></ArticleIdList></Reference><Reference><Citation>Witberg G., Barda N., Hoss S., Richter I., Wiessman M., Aviv Y., Grinberg T., Auster O., Dagan N., Balicer R.D., et al. Myocarditis after Covid-19 Vaccination in a Large Health Care Organization. N. Engl. J. Med. 2021;385:2132&#x2013;2139. doi: 10.1056/NEJMoa2110737.</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMoa2110737</ArticleId><ArticleId IdType="pmc">PMC8531986</ArticleId><ArticleId IdType="pubmed">34614329</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee G.M., Hopkins R.H. COVID-19 Vaccine Safety Technical (VaST) Work Group 2021.  [(accessed on 30 August 2021)]; Available online:  https://www.cdc.gov/vaccines/acip/work-groups-vast/index.html.</Citation></Reference><Reference><Citation>Patel T., Kelleman M., West Z., Peter A., Dove M., Butto A., Oster M.E. Comparison of MIS-C Related Myocarditis, Classic Viral Myocarditis, and COVID-19 Vaccine related Myocarditis in Children. medRxiv. 2021 doi: 10.1101/2021.10.05.21264581.</Citation><ArticleIdList><ArticleId IdType="doi">10.1101/2021.10.05.21264581</ArticleId><ArticleId IdType="pmc">PMC9238597</ArticleId><ArticleId IdType="pubmed">35475362</ArticleId></ArticleIdList></Reference><Reference><Citation>Yang H. Benefits-Risks of Pfizer-BioNTech COVID-19 Vaccine for Ages 5 to 11 Years 2021. FDA VRBPAC; Silver Spring, MD, USA: 2021.</Citation></Reference><Reference><Citation>Orvieto R., Noach-Hirsh M., Segev-Zahav A., Haas J., Nahum R., Aizer A. Does mRNA SARS-CoV-2 vaccine influence patients&#x2019; performance during IVF-ET cycle? Reprod. Biol. Endocrinol. 2021;19:69. doi: 10.1186/s12958-021-00757-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12958-021-00757-6</ArticleId><ArticleId IdType="pmc">PMC8116639</ArticleId><ArticleId IdType="pubmed">33985514</ArticleId></ArticleIdList></Reference><Reference><Citation>Bentov Y., Beharier O., Moav-Zafrir A., Kabessa M., Godin M., Greenfield C.S., Ketzinel-Gilad M., Ash Broder E., Holzer H.E.G., Wolf D., et al. Ovarian follicular function is not altered by SARS-CoV-2 infection or BNT162b2 mRNA COVID-19 vaccination. Hum. Reprod. 2021;36:2506&#x2013;2513. doi: 10.1093/humrep/deab182.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/humrep/deab182</ArticleId><ArticleId IdType="pmc">PMC8385874</ArticleId><ArticleId IdType="pubmed">34364311</ArticleId></ArticleIdList></Reference><Reference><Citation>Kharbanda E.O., Haapala J., DeSilva M., Vazquez-Benitez G., Vesco K.K., Naleway A.L., Lipkind H.S. Spontaneous Abortion Following COVID-19 Vaccination During Pregnancy. JAMA. 2021;326:1629&#x2013;1631. doi: 10.1001/jama.2021.15494.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.2021.15494</ArticleId><ArticleId IdType="pmc">PMC8427483</ArticleId><ArticleId IdType="pubmed">34495304</ArticleId></ArticleIdList></Reference><Reference><Citation>Morris R.S. SARS-CoV-2 spike protein seropositivity from vaccination or infection does not cause sterility. F&amp;S Rep. 2021;2:253&#x2013;255. doi: 10.1016/j.xfre.2021.05.010.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.xfre.2021.05.010</ArticleId><ArticleId IdType="pmc">PMC8169568</ArticleId><ArticleId IdType="pubmed">34095871</ArticleId></ArticleIdList></Reference><Reference><Citation>Zauche L.H., Wallace B., Smoots A.N., Olson C.K., Oduyebo T., Kim S.Y., Petersen E.E., Ju J., Beauregard J., Wilcox A.J., et al. Receipt of mRNA Covid-19 Vaccines and Risk of Spontaneous Abortion. N. Engl. J. Med. 2021;385:1533&#x2013;1535. doi: 10.1056/NEJMc2113891.</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMc2113891</ArticleId><ArticleId IdType="pmc">PMC8451181</ArticleId><ArticleId IdType="pubmed">34496196</ArticleId></ArticleIdList></Reference><Reference><Citation>Magnus M.C., Gjessing H.K., Eide H.N., Wilcox A.J., Fell D.B., H&#xe5;berg S.E. Covid-19 Vaccination during Pregnancy and First-Trimester Miscarriage. N. Engl. J. Med. 2021;385:2008&#x2013;2010. doi: 10.1056/NEJMc2114466.</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMc2114466</ArticleId><ArticleId IdType="pmc">PMC8552533</ArticleId><ArticleId IdType="pubmed">34670062</ArticleId></ArticleIdList></Reference><Reference><Citation>Safrai M., Rottenstreich A., Herzberg S., Imbar T., Reubinoff B., Ben-Meir A. Stopping the misinformation: BNT162b2 COVID-19 vaccine has no negative effect on women&#x2019;s fertility. medRxiv. 2021 doi: 10.1101/2021.05.30.21258079.</Citation><ArticleIdList><ArticleId IdType="doi">10.1101/2021.05.30.21258079</ArticleId></ArticleIdList></Reference><Reference><Citation>Gonzalez D.C., Nassau D.E., Khodamoradi K., Ibrahim E., Blachman-Braun R., Ory J., Ramasamy R. Sperm Parameters Before and After COVID-19 mRNA Vaccination. JAMA. 2021;326:273&#x2013;274. doi: 10.1001/jama.2021.9976.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.2021.9976</ArticleId><ArticleId IdType="pmc">PMC8293015</ArticleId><ArticleId IdType="pubmed">34137808</ArticleId></ArticleIdList></Reference><Reference><Citation>Safrai M., Reubinoff B., Ben-Meir A. BNT162b2 mRNA Covid-19 vaccine does not impair sperm parameters. medRxiv. 2021 doi: 10.1101/2021.04.30.21255690.</Citation><ArticleIdList><ArticleId IdType="doi">10.1101/2021.04.30.21255690</ArticleId><ArticleId IdType="pmc">PMC8801893</ArticleId><ArticleId IdType="pubmed">35279377</ArticleId></ArticleIdList></Reference><Reference><Citation>Male V. Menstrual changes after covid-19 vaccination. BMJ. 2021;374:n2211. doi: 10.1136/bmj.n2211.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmj.n2211</ArticleId><ArticleId IdType="pubmed">34526310</ArticleId></ArticleIdList></Reference><Reference><Citation>RCOG/FSRH Respond to Reports of 30,000 Women&#x2019;s Periods Affected after COVID-19 Vaccine.  [(accessed on 2 November 2021)].  Available online:  https://www.rcog.org.uk/en/news/rcogfsrh-responds-to-reports-of-30000-womens-periods-affected-after-covid-19-vaccine/</Citation></Reference><Reference><Citation>Comirnaty COVID-19 Vaccine: EMA Recommends Approval for Children Aged 5 to 11|European Medicines Agency.  [(accessed on 21 December 2021)].  Available online:  https://www.ema.europa.eu/en/news/comirnaty-covid-19-vaccine-ema-recommends-approval-children-aged-5-11.</Citation></Reference><Reference><Citation>Coronavirus Vaccine&#x2014;Weekly Summary of Yellow Card Reporting&#x2014;GOV.UK.  [(accessed on 15 November 2021)]; Available online:  https://www.gov.uk/government/publications/coronavirus-covid-19-vaccine-adverse-reactions/coronavirus-vaccine-summary-of-yellow-card-reporting.</Citation></Reference><Reference><Citation>Bar-On Y.M., Goldberg Y., Mandel M., Bodenheimer O., Freedman L., Kalkstein N., Mizrahi B., Alroy-Preis S., Ash N., Milo R., et al. Protection of BNT162b2 Vaccine Booster against Covid-19 in Israel. N. Engl. J. Med. 2021;385:1393&#x2013;1400. doi: 10.1056/NEJMoa2114255.</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMoa2114255</ArticleId><ArticleId IdType="pmc">PMC8461568</ArticleId><ArticleId IdType="pubmed">34525275</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>